Hogan Lovells advised Mind Medicine Inc. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), completed its underwritten public offering of 9,285,511 common shares, without value, at an offering...
Mind Medicine Inc’s $75 Million Common Shares Offering
Mind Medicine’s $175 Million Common Shares Private Placement
Hogan Lovells advised Mind Medicine on the deal. Clinical stage biopharmaceutical company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), completed its underwritten offering of 16,666,667 common shares,...
Armira Growth’s €25 Million Minority Investment in osapiens
Hogan Lovells has advised Armira Growth. Armira Growth, part of Munich-based investment holding Armira, has completed a €25 million minority investment in ESG software pioneer osapiens. This...
Bain Capital’s Acquisition of 20% Stake in IMS Nanofabrication GmbH from Intel
Hogan Lovells guides Intel in sale of stake in IMS Nanofabrication business to Bain. Vienna, Austria-based IMS is an industry leader in multi-beam mask writing for...
Equifax Inc.’s Acquisition of Boa Vista Serviços
Hogan Lovells represented Equifax Inc. on the deal. Equifax Inc. signed its definitive agreement to acquire Boa Vista Serviços in a deal that will enable Equifax...
GXO Logistics, Inc.’s £1 Billion Takeover of Clipper Logistics plc
Hogan Lovells advised Clipper Logistics on the deal, while Wachtell, Lipton, Rosen & Katz and Freshfields Bruckhaus Deringer advised GXO. The transaction was formally announced on...
Labcorp’s Strategic Laboratory Agreement With Ascension
Hogan Lovells advised Labcorp on the deal while Jones Day represented Ascension. Labcorp, a leading global life sciences company, signed an agreement to create a comprehensive...
Zendesk Inc.’s Acquisition of Momentive
Hogan Lovells advised Zendesk on the deal. Latham & Watkins represented JP Morgan, financial advisor to Momentive. Wilson Sonsini advised Momentive. Zendesk (NYSE: ZEN) and Momentive (NASDAQ:...
Allergan Aesthetics’ US$550 Million Acquisition Of Soliton and RESONIC
Hogan Lovells advised Soliton on the deal. Allergan Aesthetics, an AbbVie company, will acquire Soliton and RESONIC, its Rapid Acoustic Pulse device, for approximately US$550 million....